Follicum files patent application for new topical formulation of FOL-005 for hair loss
Using easy-to-apply cream instead of direct scalp injection would extend patent protection by 8 years Follicum AB ("Follicum" or "the company") today announced that the company's hair loss treatment projects are progressing according to plan and a patent application for an internally developed formulation of FOL-005 has been submitted. The cream formulation is intended to be lubricated into the scalp and has demonstrated good hair-stimulating effect in an animal model. The next step involves running a clinical phase II study in alopecia patients which is expected to start at the end of